Stay Informed: Medical and Research Updates

Glaucoma Fact Sheets

The fact sheets on this page are in PDF format.
(Adobe Reader is required to view or print PDF documents)

Glaucoma Treatments

The most common treatments for glaucoma are eye drops and, rarely, pills. There are a number of different categories of eye drops, but all are used to either decrease the amount of fluid (aqueous humor) in the eye or improve its outward flow. Sometimes doctors will prescribe a combination of eye drops. People using these medications should be aware of their purpose and potential side effects, which should be explained by a medical professional. Learn more...

Healthy Living with Glaucoma

For people with glaucoma or at risk of developing it, a healthy lifestyle that includes regular exercise and a nutritious diet is especially important. In addition to benefiting overall physical and mental well-being, it promotes eye health. Maintaining mental and emotional health is also important. Learn more...

Essential Questions to Ask Your Doctor About Glaucoma

Take an active role in managing your healthcare by having an open conversation with your doctor. Write down your questions ahead of time, and don't leave the office without understanding the recommendations for your condition, your doctor's responsibilities, and your responsibilities. Learn more...

Glaucoma: Frequently Asked Questions

Glaucoma is the name given to a group of eye diseases that lead to damage of the optic nerve (the bundle of nerve fibers that carries information from the eye to the brain), which can then lead to vision loss and possibly blindness. Optic nerve damage usually occurs in the presence of high eye pressure; however, it can occur with normal or even less than normal eye pressure. Read the answers to the most frequently asked question about this eye disease.

Clinical Trial Information for Glaucoma

It can take many years for a potential treatment for macular degeneration to work its way from the laboratory to rigorous testing and, finally, approval by the U.S. Food and Drug Administration (FDA). The process begins in the lab with basic investigations using cells and specially bred animal models. Next, translational research moves the therapy to the human setting. Finally, the drug is tested on humans in clinical trials divided into three phases: I, II, and III. Learn more...